Skip to main content
Clinical Trials/IRCT2013123116016N1
IRCT2013123116016N1
Completed
Phase 3

A comparative study between the efficacy of oral Cimetidine and low dose of systemic Meglumine Antimoniate (MA) with standard dose of systemic (MA) in the treatment of syrian cutaneous leishmaniasis patients.

The University of Aleppo0 sites90 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
The University of Aleppo
Enrollment
90
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The University of Aleppo

Eligibility Criteria

Inclusion Criteria

  • parasitological confirmation; age between 5 to 65 years old; normal values of the liver, kidney, and pancreas function tests and EKG before treatment.
  • Exclusion criteria: contraindication to use (MA); pregnant and lactating women; patients with history of cardiac, renal and hepatic diseases; those under treatment with other drugs during the month prior to commencement of the study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials